JBF Capital’s AbbVie ABBV Stock Holding History

JBF Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-100,000	Closed	-$5.44M	–	140
2015 Q3	$5.44M	Hold	100,000	–	–	0.74%	10
2015 Q2	$6.72M	Buy	100,000 +39,300	+65%	+$2.57M	0.9%	7
2015 Q1	$3.55M	Hold	60,700	–	–	0.51%	7
2014 Q4	$3.97M	Hold	60,700	–	–	0.57%	10
2014 Q3	$3.51M	Hold	60,700	–	–	0.52%	9
2014 Q2	$3.43M	Buy	+60,700	New	+$3.18M	0.5%	12

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JBF Capital's ABBV Position: Q4 2015 in Review

JBF Capital sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 100,000 shares — an estimated $5.44M sold.

JBF Capital first reported a position in ABBV in Q2 2014 and held it in 6 quarters. The position peaked at $6.72M in Q2 2015. 1,637 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

JBF Capital reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
JBF Capital sold 100,000 AbbVie shares in Q4 2015, an estimated $5.44M.
JBF Capital first reported a position in AbbVie in Q2 2014 and held it in 6 quarters.
JBF Capital's AbbVie position peaked at $6.72M in Q2 2015.
1,637 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on JBF Capital's 13F filing for Q4 2015, filed 10 Feb 2016.